KOY.MU KOBAYASHI PHARM

Other Metals & Mining Munich Exchange
- EUR
Market cap
-
P/E
326.7x
P/B
1.95x
ROE
1.7%
Dividend yield
85.38%
Fundamental score
1.3/5

Ratios use the latest price and the fiscal year ending Dec 2025.

Is KOY.MU undervalued?

Graham number

The Graham number of KOBAYASHI PHARM cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

KOBAYASHI PHARM fundamental analysis

6 of 22 checks passed

ROE 0/2

Low return on equity (1.7%), below 10%.

ROA 0/1

Return on assets (1.5%) is below the industry median (3.2%).

Profit Consistency 2/2

Profitable for 9 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share did not grow over the past 5 years.

Earnings Acceleration 0/1

Last year's EPS growth (-63.7%) is not above the 5-year average (-27.5% a year).

Earnings Growth vs Industry 0/1

Last year's EPS growth (-63.7%) is below the industry median (6.0%).

Revenue Growth 0/2

Revenue shrank 0.1% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 0/2

Debt to equity cannot be calculated: debt is not reported or equity is negative.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Debt Coverage 0/1

Debt is not reported.

Interest Coverage 1/1

EBIT is 134.7x against interest expense, well covered.

PE vs Market 0/1

PE (326.7x) is above the market median (16.6x).

PE vs Industry 0/1

PE (326.7x) is above the industry median (16.6x).

PBV 0/1

Price to book (2.0x) is above the industry median (1.8x).

Graham Number 0/1

The price is above the Graham number (PE x PB = 638.2, limit 22.5).

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

Dividend yield (0.6%) is in the bottom 25% of dividend payers in the market.

Dividend Stability 1/2

Dividends paid without a cut of more than 10% for 9 years.

Dividend Growth 1/1

Dividends paid grew over the past 5 years.

Payout Ratio 0/1

Payout ratio is 209.3%, above 90% of earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

KOBAYASHI PHARM stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About KOBAYASHI PHARM

There is no Profile data available for KOY.MU.

Full company profile